|
Friday, January 20, 2023 |
|
醫思健康料23財年第三季銷售額按年升不少於8% |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,集團預計截至2022年10月至12月(「季內」)之銷售額較去年同期上升不少於8%。 more info >> |
|
EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects sales volume for the period of October to December 2022 (the "Quarter") to increase by no less than 8% as compared with the same period last year. more info >> |
|
Tuesday, January 10, 2023 |
|
医思健康向赴港旅客提供复必泰二价疫苗服务 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,集团将透过旗下医疗中心向年满18岁的赴港旅客提供复必泰二价疫苗服务。 more info >> |
|
醫思健康向赴港旅客提供復必泰二價疫苗服務 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,集團將透過旗下醫療中心向年滿18歲的赴港旅客提供復必泰二價疫苗服務。 more info >> |
|
Wednesday, December 14, 2022 |
|
EC Healthcare wins "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022 |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, is pleased to announce the Group has garnered the "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022. more info >> |
|
医思健康夺得投资者关系杂志大中华区医疗健康行业公司最高荣誉奖 |
香港最大非医院医疗服务机构* ── 医思健康(「公司」,连同附属公司,总称「集团」;香港联交所股份编号:2138)欣然宣布,《投资者关系杂志》举办之2022 年度大中华区奖项评选中,集团于医疗健康行业公司中夺得最高荣誉奖。 more info >> |
|
醫思健康奪得投資者關係雜誌大中華區醫療健康行業公司最高榮譽獎 |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)欣然宣佈,《投資者關係雜誌》舉辦之2022 年度大中華區獎項評選中,集團於醫療健康行業公司中奪得最高榮譽獎。 more info >> |
|
Thursday, November 24, 2022 |
|
医思健康公布2022/23年度中期业绩 医疗服务业务推动收入同比增长31.1% |
香港最大非医院医疗服务机构* ── 医思健康(“公司”,连同附属公司,总称“集团”;香港联交所股份编号:2138)公布截至2022年9月30日止六个月(“期内”)未经审核之中期业绩。 more info >> |
|
醫思健康公佈2022/23年度中期業績 醫療服務業務推動收入同比增長31.1% |
香港最大非醫院醫療服務機構* ── 醫思健康(「公司」,連同附屬公司,總稱「集團」;香港聯交所股份編號:2138)公佈截至2022年9月30日止六個月(「期內」)未經審核之中期業績。 more info >> |
|
EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30 September 2022 (the "Period"). more info >> |
|
|
|